CIBC Private Wealth Group
RVMD icon

CIBC Private Wealth Group’s Revolution Medicines RVMD Stock Holding History

CIBC Private Wealth Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$217K Buy
2,720
+2,717
+90,567% +$178K ﹤0.01% 1153
2025
Q3 		$140 Hold
3
– – ﹤0.01% 2965
2025
Q2 		$110 Hold
3
– – ﹤0.01% 2962
2025
Q1 		$93 Buy
+3
New +$122 ﹤0.01% 2997
2024
Q4 		– Sell
-700
Closed -$31.7K – 3152
2024
Q3 		$31.7K Hold
700
– – ﹤0.01% 1952
2024
Q2 		$27.7K Hold
700
– – ﹤0.01% 1909
2024
Q1 		$22.2K Buy
+700
New +$20.7K ﹤0.01% 2009

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIBC Private Wealth Group's RVMD Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Revolution Medicines (RVMD) stake by 90,567% in Q4 2025, buying an estimated $178K and bringing the position to 2,720 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

CIBC Private Wealth Group first reported a position in RVMD in Q1 2024 and has held it in 7 quarters since. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • CIBC Private Wealth Group held 2,720 shares of Revolution Medicines worth $217K as of Q4 2025.
  • CIBC Private Wealth Group bought 2,717 Revolution Medicines shares in Q4 2025, an estimated $178K.
  • Revolution Medicines made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1153 holding.
  • CIBC Private Wealth Group first reported a position in Revolution Medicines in Q1 2024 and has held it in 7 quarters since.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.